U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C8H10AsN2O4.2Na.H2O
Molecular Weight 610.19
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TRYPARSAMIDE HEMIHYDRATE

SMILES

O.[Na+].[Na+].NC(=O)CNC1=CC=C(C=C1)[As](O)([O-])=O.NC(=O)CNC2=CC=C(C=C2)[As](O)([O-])=O

InChI

InChIKey=CGSBXNNKDCWLRS-UHFFFAOYSA-L
InChI=1S/2C8H11AsN2O4.2Na.H2O/c2*10-8(12)5-11-7-3-1-6(2-4-7)9(13,14)15;;;/h2*1-4,11H,5H2,(H2,10,12)(H2,13,14,15);;;1H2/q;;2*+1;/p-2

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C8H10AsN2O4
Molecular Weight 273.0976
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Tryparsamide is an arsenic compound with activity against Spirochaetes bacteria. Tryparsamide is used in the treatment of syphilis and African sleeping sickness. For decades Tryparsamide remained the standard treatment for trypanosomiasis. Tryparsamide has two remarkable properties: first, it increases the resistance of the individual by improving his general physical status; and, second, the high penetrability for nervous tissue which it possesses may increase the potential spirocheticidal action of the drug.

Approval Year

PubMed

PubMed

TitleDatePubMed
Tryparsamide Therapy of Neurosyphilis in Negroes.
1931 Jul
General Discussion on Tryparsamide and Stovarsol: Meeting of The Medical Society for the Study of Venereal Diseases. London. July 13th, 1940.
1941 Jan
The present status of tryparsamide in syphilotherapy.
1947 May

Sample Use Guides

The proper dosage for the average individual is to 3 grams of the drug. This amount dissolved in 10-20 cc. of sterile distilled water is given weekly. It may be given subcutaneously, intramuscularly or intravenously. The intravenous route is the preferable one to use. It should be given slowly by the syringe method.
Route of Administration: Parenteral
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:36:25 GMT 2023
Edited
by admin
on Sat Dec 16 09:36:25 GMT 2023
Record UNII
38892Q01QB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TRYPARSAMIDE HEMIHYDRATE
MI  
Common Name English
ARSONIC ACID, (4-((2-AMINO-2-OXOETHYL)AMINO)PHENYL)-, MONOSODIUM SALT, HYDRATE (2:1)
Systematic Name English
AS-(4-((2-AMINO-2-OXOETHYL)AMINO)PHENYL)ARSONIC ACID SODIUM SALT (1:1), HEMIHYDRATE
Systematic Name English
TRYPARSAMIDE 0.5 HYDRATE
Common Name English
TRYPARSAMIDE HEMIHYDRATE [MI]
Common Name English
Code System Code Type Description
CAS
6159-29-1
Created by admin on Sat Dec 16 09:36:26 GMT 2023 , Edited by admin on Sat Dec 16 09:36:26 GMT 2023
PRIMARY
FDA UNII
38892Q01QB
Created by admin on Sat Dec 16 09:36:26 GMT 2023 , Edited by admin on Sat Dec 16 09:36:26 GMT 2023
PRIMARY
PUBCHEM
91618135
Created by admin on Sat Dec 16 09:36:26 GMT 2023 , Edited by admin on Sat Dec 16 09:36:26 GMT 2023
PRIMARY
EPA CompTox
DTXSID101333778
Created by admin on Sat Dec 16 09:36:26 GMT 2023 , Edited by admin on Sat Dec 16 09:36:26 GMT 2023
PRIMARY
MERCK INDEX
m11244
Created by admin on Sat Dec 16 09:36:26 GMT 2023 , Edited by admin on Sat Dec 16 09:36:26 GMT 2023
PRIMARY Merck Index
Related Record Type Details
ANHYDROUS->SOLVATE